Drugs / High-dose cytarabine
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02518750 Background | Nov 2016 → Mar 2018 | T-cell leukemia, acute lymphoblastic leukemia | St. Jude Children's Research Hospital | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | High-dose cytarabine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02518750 ↗ |
| Route | Intravenous | “High-dose cytarabine 3 g/m\^2 IV” NCT02518750 ↗ |